Lower detection of prostate cancer with PSA screening in US than in a European randomised trial

Tuesday, February 9, 2010 - 09:00 in Health & Medicine

Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S. than in a European randomised trial because of lower screening sensitivity, according to a new brief communication published online February 8 in the Journal of the National Cancer Institute...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net